Retatrutide, the next big GLP-1
The starting dose uses the least product per week, making it the most affordable phase of the protocol
Su triple mecanismo La retatrutida acta como un agonista triple, activando de manera simultnea los receptores GLP-1, GIP y glucagn
It helps support and repair the skin barrier, improves wound healing, calms inflammation, and prompts collagen and elastin formation to help firm the skin and soften fine lines
These innovative biologics have revolutionized diabetes management by offering superior glycemic control alongside significant weight loss benefits, positioning them as preferred treatment options over traditional therapies
Recent studies show a complex link between GLP-1 receptor agonists and mental health